Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping

A venous thromboembolism (VTE) with the subsequent risk of pulmonary embolism is a major concern in the treatment of patients with multiple myeloma with thalidomide. The susceptibility to developing a VTE in response to thalidomide therapy is likely to be influenced by both genetic and environmental...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Johnson, David C., Corthals, Sophie, Ramos, Christine, Hoering, Antje, Cocks, Kim, Dickens, Nicholas J., Haessler, Jeff, Goldschmidt, Harmut, Child, J. Anthony, Bell, Sue E., Jackson, Graham, Baris, Dalsu, Rajkumar, S. Vincent, Davies, Faith E., Durie, Brian G. M., Crowley, John, Sonneveld, Pieter, Van Ness, Brian, Morgan, Gareth J.
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2008
Sujets:
Hemostasis, Thrombosis, and Vascular Biology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3601865/
https://ncbi.nlm.nih.gov/pubmed/18805967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-02-140434
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires